The rate of new chronic obstructive pulmonary disease (COPD) cases decreased from 2001 to 2020, although the prevalence of ...
Released positive topline data from Phase 1 study of IV rademikibart in patients with asthma or COPD –– Results from Phase 3 study of ...
Canada is entering another wildfire season -- and for millions of Canadians living with lung disease, the danger often begins before the smoke is even visible. The record-breaking 2023 wildfire season ...
March 27 () - AstraZeneca said on Friday its experimental respiratory treatment tozorakimab showed a meaningful reduction in ...
The Efficacy and Safety of Triple Therapy in Obstructive Lung Disease (ETHOS) and Informing the Pathway of Chronic ...
Goldman Sachs 9th Annual Biopharma Innovation Summit March 26, 2026 5:00 AM EDTCompany ParticipantsKaivan Khavandi - Senior VP, Global Head ...
Introduction Specialised literature demonstrates that chronic obstructive pulmonary disease (COPD) has patho-physiological changes that impair cardiac autonomic function and the ability of the ...
Russell Winwood's chronic obstructive pulmonary disease (COPD) diagnosis in 2011 was a brutal wake-up call. His second in less than a decade. The Brisbane native, who came to be known as the “COPD ...
APEX Part A data demonstrated durable maintenance of response at 52-weeks for every 3- and 6-months dosing, respectively, ...
The 18th annual Fight For Air Climb took place Saturday, March 21, at the 411 E. Wisconsin building to benefit the American ...
Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results